Document is current
Any future updates will be listed below
-
Authors
Gross, Ben J.
Donahue, Allison
Ford, James S.
Lu, Xiaolei
Boussina, Aaron
Malhotra, Atul
Zheng, Kai
Nemati, Shamim
Wardi, Gabriel
-
Funding
Funding for this research was provided by:
U.S. National Library of Medicine,United States (T15 LM011271, T15 LM011271, R01LM013998)
National Institutes of Health,United States (K23GM146092, K23GM146092, K23GM146092)
University of California, Multicampus Research Programs and Initiatives (M25PR9018, M25PR9018, M25PR9018)
National Institute of Allergy and Infectious Diseases (R42AI177108, R42AI177108, R42AI177108)
National Institute of General Medical Sciences,United States (R35GM143121)
National Science Foundation (2405974)
- License Information
-
More Information
Article History
Received: 27 February 2025
Accepted: 5 June 2025
First Online: 14 July 2025
Declarations
:
: Institutional review board approval with waiver of informed consent was obtained.
: Not applicable.
: S.N., A. B., and A.M. are cofounders, advisors, and hold equity in Clairyon Inc. (formerly Healcisio Inc.), a medical software startup. The terms of this arrangement have been reviewed and approved by the UC San Diego in accordance with its conflict-of-interest policies. S.N. and A.M. report income from Powell Mansfield, a startup focused on diagnosis of sleep disordered breathing. A.M. additionally reports income related to medical education from Livanova, Eli Lilly, and Zoll. The remaining authors declare no competing interests.
